-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESBlog
Evaluation of Implementation of Regional Flagship Areas in the WHO South-East Asia Region 2014-2018
Nov 24, 2020
IQVIA ‘s public health division provides different services in the health domain. With the overall objective of improving health and impacting people through innovation, data driven solutions, IQVIA aims to catalyze the ‘health for all’ mission. One of the key areas it worked for instance was the independent evaluation of WHO-SEARO project. This ensured that different stakeholders-decision makers at WHO, Ministry officials and health experts were enabled with over-arching, critical analyses of the project. It aimed to assess the relevance, effectiveness and efficiency of WHO ‘s role in progress and impact on the regional flagship areas (2014-18). The independent evaluation also provided individual recommendations, challenges along with overall analysis. The eight regional flagship areas included measles elimination and rubella control, prevention of NCDs, unfinished MDGs agenda, UHC, AMR, scaling capacity development in emergency risk management countries, finishing the unfinished business of elimination of Kala Azar, leprosy, lymphatic filariasis and yaws and acceleration of efforts to end TB by 2030. The evaluation study employed a mixed-method approach. The main reason was to support the quantitative information through qualitative findings. The process was triangulated through extensive literature reviews from 2014-2018, and key stakeholders’ interviews (which included administrative, technical leads from ministry and key technical donor agencies).
The accelerating factors were discussed in detail in order to compile the factors which enabled the member states to drive advancements on flagship areas. Factors which helped in the progress were broadly: enhanced commitment from member states, improved financial support, advocacy efforts to generate buy-in from partners, improved health systems and institutional capacity. In order to provide a 360-degree view, the challenges were classified as technical and operational. Some of the technical challenges included monitoring and evaluation, multisectoral coordination and special emphasis on equity. The operational challenges included sustainability, funding amongst others. It is worth mentioning that five countries have successfully eliminated measles and six have controlled rubella and 10 member states have enrolled in Global Antimicrobial Resistance Surveillance System (GLASS).
Since version 2.0 of Regional Flagship Area has been launched in 2019 Regional Committee Meeting the recommendation from this evaluation along with the analysis can be a guiding map. It also serves a complete in-depth analysis for such future projects.
Maheshwari N, Chauhan K, Sharma K, Sharma M, and team. IQVIA consulting & Information Services India Pvt. Ltd. 2020. Evaluation of Implementation of Regional Flagship Areas in the WHO South-East Asia Region 2014-2018. New Delhi. https://www.who.int/docs/default-source/searo/evaluation-reports/evaluation-of-implementation-of-regional-flagship-areas-in-who-sea-region-2014-18.pdf?sfvrsn=db3cad60_2